VIM and cancer: In this study we investigated whether the serum-based biomarkers of MMP-degraded type I collagen (C1M), MMP-degraded type IV collagen (C4M) and MMP-degraded citrullinated vimentin (VICM) were associated with cancer-specific mortality in a cohort of postmenopausal women diagnosed with cancer within 3 years from blood sampling.